IBD in Clinical Practice: Anemia

Gastroenterology
Curriculum:
IBD in Clinical Practice: Anemia
Credits:
1.25 AMA PRA Category 1 Credit(s)™
Launch Date:
25-Oct-16
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Gastroenterologists and gastroenterology nurse practitioners (NPs) and physician assistants (PAs)

Relevant Terms:

Anemia, IBD

Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI

Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Associate Professor of Medicine
Harvard Medical School
Gastroenterologist
Director Translational Research, Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Boston, MA

Alan C. Moss, MD, graduated from the Royal College of Surgeons in Ireland and earned his doctorate at University College Dublin. He completed a residency and fellowship at Mater Misericoradiae University Hospital, and an advanced fellowship at Beth Israel Deaconess Medical Center (BIDMC) in Boston.

Dr. Moss is Director Translational Research at the Center for Inflammatory Bowel Disease and Program Director for the IBD Fellowship program at BIDMC. He is also an attending gastroenterologist at BIDMC and Associate Professor of Medicine at Harvard Medical School.

Dr. Moss's research interests include fecal transplantation and the analysis of intestinal luminal fluid for exosomal RNA as a means of monitoring disease activity in inflammatory bowel disease (IBD). He has edited multiple books, authored 11 book chapters, and has been published in over 100 peer-reviewed papers and periodicals including Gut, Clinical Gastroenterology & Hepatology, American Journal of Gastroenterology, Inflammatory Bowel Diseases, and the European Journal of Immunology. He is an Associate Editor for the Journal of Crohn's & Colitis, Frontline Gastroenterology (BMJ), and the World Journal of Gastroenterology.

Dr. Moss is a fellow of the American College of Gastroenterology, the American Gastroenterology Association (AGA), and the European Board of Gastroenterology. He has served on the National Immunology & Inflammatory Bowel Diseases Section of the AGA Institute Council, and is part of the Pilot Study Steering Committee of the Crohn's & Colitis Foundation of America (CCFA) Clinical Research Alliance, as well as the National Professional Education Committee of CCFA.

Raluca Vrabie, MD

Raluca Vrabie, MD
Assistant Professor of Clinical Medicine
Stony Brook School of Medicine
IBD Program Director
Winthrop University Hospital
Mineola, NY

Raluca Vrabie, MD, graduated from Cooper Union with a Bachelor's in Chemical Engineering. She earned her medical degree from Mount Sinai School of Medicine where she also completed a residency in Internal Medicine. She completed her GI training at the Hospital of the University of Pennsylvania in Philadelphia.
 
Dr. Vrabie is a gastroenterologist on faculty at Winthrop University Hospital, located in Mineola, New York. She is Director of the Winthrop Inflammatory Bowel Disease (IBD) Center. Dr. Vrabie has an academic appointment from Stony Brook School of Medicine, where she is an Assistant Professor of Clinical Medicine, and she is the gastroenterology fellowship director at Winthrop University Hospital. Her practice model is based on patient engagement in the decision-making process and includes detailed discharge instruction sheets, phone calls to explain lab results, and webinars detailing medication side effects.
 
Dr. Vrabie is very active locally and nationally in the Crohn's and Colitis Foundation of America (CCFA). Locally, she sits on the board of the Long Island chapter, and she is co-president of the CMAC (chapter medical advisory committee). She captains a team for the annual walk Take Steps and speaks for events such as the Family Symposium or Program in a Box. She is also a member of the national CCFA Professional Education committee. 

Jason K. Hou, MD, MS

Jason K. Hou, MD, MS
Assistant Professor of Medicine
Research Director, Inflammatory Bowel Disease Center
Program Director, Gastroenterology Fellowship Program
Baylor College of Medicine
Medical Director, Inflammatory Bowel Diseases
Michael E. DeBakey VA Medical Center
Houston, TX

Jason K. Hou, MD, MS received his medical degree from Northwestern University Feinberg School of Medicine in Chicago, Illinois. He completed his residency and a fellowship in gastroenterology and hepatology at Baylor College of Medicine in Houston, Texas. He was Chief Medical Resident at the Michael E. DeBakey VA Medical Center and St. Luke's Episcopal Hospital.
 
Dr. Hou is on the medical staff at Baylor St. Luke’s Medical Center and a staff physician at the Michael E. DeBakey VA Medical Center, where he is Medical Director of Inflammatory Bowel Diseases. He is Assistant Professor of Medicine and Research Director of the Inflammatory Bowel Disease Center at Baylor College of Medicine.
 
Dr. Hou’s clinical and research focus is on clinical outcomes, quality improvement, and patient-centered comparative effectiveness of colorectal cancer prevention in patients with IBD. Dr. Hou’s work appears in more than 50 abstracts and he has been published in almost as many peer-reviewed manuscripts. He has been an invited presenter and speaker in numerous meetings and conferences across the county.
 
Dr. Hou is a member of the American Gastroenterology Association, the American College of Gastroenterology (ACG), and the Crohn’s and Colitis Foundation of America (CCFA). He is an expert moderator in the ACG & CCFA IBD Circle and he is on the executive board and Chapter Medical Advisory Committee Co-Chair of the South Texas Chapter of CCFA.
1. Identify IBD patients with anemia or iron deficiency
2. Summarize evaluation criteria for anemia or iron deficiency using the CCFA IBD Anemia Care Pathway
3. Describe intervention and follow-up steps outlined by the CCFA IBD Anemia Care Pathway for patients who have anemia or iron deficiency
4. Engage IBD patients with anemia or iron deficiency in their healthcare by implementing effective shared decision making strategies

PHYSICIAN CONTINUING MEDICAL EDUCATION
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine, the Crohn’s & Colitis Foundation of America (CCFA), and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Jason K. Hou, MD, MS, has affiliations with Pfizer, UCB (Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents); Celgene, AbbVie, Pfizer, Redhill Biopharma (Contracted Research); AbbVie, UCB, Valeant (Speaker’s Bureau)
  • Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI, has no affiliations with commercial interests to disclose.
  • Raluca Vrabie, MD, has no affiliations with commercial interests to disclose.
Crohn’s & Colitis Foundation of America
  • Orna Ehrlich, MPH, has no affiliations with commercial interests to disclose.
RMEI Medical Education, LLC
  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests to disclose.
Postgraduate Institute for Medicine
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
 
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
 
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
  
Estimated time to complete: 1.25 hours
Medium: Internet

FEE INFORMATION
There is no fee for this educational activity.

COMMERCIAL SUPPORT
This activity is jointly provided by Postgraduate Institute for Medicine, the Crohn's & Colitis Foundation of America, and RMEI Medical Education, LLC. This activity is supported by an independent medical educational grant from Luitpold Pharmaceuticals.

HOW TO RECEIVE CREDIT
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.25 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
 
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above